Cogent to Launch Cancer Survivorship System at 49th Annual Meeting of the American Society for Therapeutic and Radiation Oncology

As follow-up to a successful pre-launch debut at the ASCO Annual Meeting in June of this year, Cogent will launch EQUICARE CS™, its’ much anticipated Cancer Survivorship system, at the 49th Annual Meeting of the American Society for Therapeutic and Radiation Oncology (ASTRO). This year’s meeting will be held October 28 – November 1, 2007 in Los Angeles.

ASTRO’s Annual Meeting is the premier scientific meeting in radiation oncology. Its purpose is to address the educational needs of radiation oncologists, physicists, biologists, nurses and other healthcare professionals involved in the field of radiation oncology, as well as oncologists working in related specialties. Over 11,000 delegates from around the globe are expected to attend this year’s annual meeting.

Cogent President & CEO, Len Grenier has this to say about the company’s imminent launch.

“ASTRO’s Annual Meeting provides the ideal venue for the first phase of our commercial launch of EQUICARE CS™. The delegates and attendees at this meeting represent our target audience and are the same individuals who have provided much of the input during our development phase. We believe EQUICARE CS™ will provide a vital and essential link for management of cancer patients post therapy.”

EQUICARE CS™ is a web-based, patient-centric approach which enhances a care team’s ability to collaborate with the patient in an efficient and secure manner. A dynamic link is created between all the stakeholders in a cancer survivor’s on-going recovery.  As cancer survival rates continue to rise, more and more emphasis will be placed on the on-going care of cancer survivors. Currently, there are over 13 million cancer survivors living in the United States. Nearly 1 million new survivors are added each year thanks to earlier detection and improved treatment methods.

“Feedback from several prominent US cancer treatment facilities indicates a strong desire to integrate a cancer survivorship tool with existing oncology information systems,” states Grenier. “Healthcare providers see EQUICARE CS™ as a way to improve patient outcomes and retain patients during the critical stages of recovery.”

About ASTRO:

Founded in 1958, ASTRO’s mission is to advance the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving healthcare environment.

About Cogent Health Solutions:

Cogent is a developer of disease case management software, solutions, and services for health care providers, patients and patient families. Improved survivorship care is critical to managing outcomes of life threatening diseases like cancer.  The promise of more effective surveillance and ongoing structured evidence-based care, will provide for better patient outcomes, and healthcare system efficiency gains. This is the opportunity that fuels our drive to achieve. Cogent is focused on setting the new benchmark for patient management in cancer treatment facilities around the globe.